Results 191 to 200 of about 429,758 (251)

Maternal and Fetal Outcomes of Pregnant Women With Sickle Cell Disease: A Single-Center Canadian Study. [PDF]

EJHaem
Lam WMJ, Rydz N, Soliman N, Goodyear D, Uminski K.   +4 more
europepmc   +1 more source

Sickle cell hemoglobin, primaquine sensitivity and their correlation. 1. Sickle cell hemoglobin.

Journal of postgraduate medicine, 1966
openaire   +1 more source

Knowledge, Attitudes and Practices about Sickle Cell Anemia in Tharu Communities of Kailali, District of Nepal

Bist BB, Kaphle HP, Sapkota KP, Shrestha B, Sapkota A, Poudel Y, Kunwar S, Paneru DP, Adhikari C.   +8 more
europepmc   +1 more source

Some of the next articles are maybe not open access.

Related searches:

Sickle Cell Hemoglobin

Sub-Cellular Biochemistry, 2020
Sickle cell hemoglobin (HbS) is an example of a genetic variant of human hemoglobin where a point mutation in the β globin gene results in substitution of glutamic acid to valine at sixth position of the β globin chain. Association between tetrameric hemoglobin molecules through noncovalent interactions between side chain residue of βVal6 and ...
Amit K Mandal, Rajdeep Das, Amrita Mitra
exaly   +3 more sources

Systematic Review of Voxelotor: A First‐in‐Class Sickle Hemoglobin Polymerization Inhibitor for Management of Sickle Cell Disease

Pharmacotherapy, 2020
Voxelotor, a sickle hemoglobin polymerization inhibitor, was approved by the U.S. Food and Drug Administration to treat sickle cell disease (SCD) in November 2019.
Jin Han, Santosh L. Saraf, V. Gordeuk
semanticscholar   +1 more source

Effect of piracetam on sickle erythrocytes and sickle hemoglobin

Biochimica et Biophysica Acta (BBA) - Protein Structure, 1981
Piracetam, 2-oxo-1-pyrrolidine acetamide, inhibits sickling of red cells containing sickle hemoglobin (Hb S). The concentration required for 50% inhibition is about 300 mM. Addition of piracetam into the supersaturated Hb S solution in concentrated phosphate buffer prolongs the delay time prior to gelation.
T, Asakura, S T, Ohnishi, K, Adachi, M, Ozguc, K, Hashimoto, M T, Devlin, E, Schwartz   +6 more
openaire   +2 more sources

Alternative diaspirins for modification of hemoglobin and sickle hemoglobin

Archives of Biochemistry and Biophysics, 1984
Studies of modification of hemoglobin and of sickle hemoglobin by alternative aspirins have been extended to a series of new bis esters with a variety of substituted bridging diacids and to a group of mono esters with polar acyl groups. Rates of hydrolysis of these alternative aspirins have also been examined, and they reveal that a careful balance ...
E J, Delaney, S E, Massil, G Y, Shi, I M, Klotz   +3 more
openaire   +2 more sources

Crowding and the polymerization of sickle hemoglobin

Journal of Molecular Recognition, 2004
AbstractUnder physiological conditions, sickle hemoglobin, a natural mutant of human hemoglobin A with a surface hydrophobic valine in place of a negatively charged glutamic acid, polymerizes at high volume occupancy. Equilibrium solubility of sickle hemoglobin entails activity coefficients that can approach 103 at high concentrations.
Frank A, Ferrone, Maria A, Rotter
openaire   +2 more sources